Mrs. April Marie Donofrio, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 301 Smith Dr Ste 3, Cranberry Township, PA 16066 Phone: 724-779-2010 Fax: 724-779-2011 |
Dawn Laraine Cogley, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 900 Commonwealth Dr Ste 900, Cranberry Township, PA 16066 Phone: 724-742-3500 Fax: 724-741-3122 |
Miranda Moore, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 301 Smith Dr Ste 3, Cranberry Township, PA 16066 Phone: 724-779-2010 Fax: 724-779-2011 |
Sally Usher, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 301 Smith Dr Ste 3, Cranberry Township, PA 16066 Phone: 724-779-2010 Fax: 724-779-2011 |
News Archive
Mylan Inc. today announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Warner Chilcott resolving litigation related to Femcon Fe Chewable Tablets, known generically as Norethindrone and Ethinyl Estradiol Tablets USP (Chewable), 0.4 mg/0.035 mg and Ferrous Fumarate Tablets USP (Chewable), 75 mg (28-Day Regimen).
CVRx, Inc., a privately held medical device company, announced today that CE Marking has been granted to expand labeling of the Barostim neo System as MR Conditional, or safe for use in Magnetic Resonance Imaging (MRI) systems under specified conditions.
African American men in Cuyahoga County have a 60% increased risk of being diagnosed with prostate cancer and an 80% increased risk of dying from prostate cancer compared to white men, according to data from the Case Comprehensive Cancer Center.
Angiogenesis is a process of new vessel formation that is activated both in physiological (tissue repair, reproduction, etc.) and pathological (myocardial infarction, diabetic retinopathy, cancer, etc.) conditions.
The AIDS Clinical Trials Group, the largest global HIV research network, which has expanded its focus to include evaluating outpatient treatment for COVID-19, today announced positive data for the monoclonal antibody combination therapy BRII-196/BRII-198 from the ACTIV-2 study of Outpatient Monoclonal Antibodies and Other Therapies.
› Verified 3 days ago